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V I R O L O G Y
Congenital Zika syndrome is associated with maternal 
protein malnutrition
J. Barbeito-Andrés1,2, P. Pezzuto3, L. M. Higa3, A. A. Dias4, J. M. Vasconcelos5, T. M. P. Santos6, 
J. C. C. G. Ferreira1, R. O. Ferreira1, F. F. Dutra4, A. D. Rossi3, R. V. Barbosa7, C. K. N. Amorim8, 
M. P. C. De Souza8, L. Chimelli9, R. S. Aguiar3, P. N. Gonzalez2, F. A. Lara10, M. C. Castro11, 
Z. Molnár12, R. T. Lopes6, M. T. Bozza4, J. L. S. G. Vianez8, C. G. Barbeito13, P. Cuervo10,  
M. Bellio4, A. Tanuri3, P. P. Garcez1*
Zika virus (ZIKV) infection during pregnancy is associated with a spectrum of developmental impairments known 
as congenital Zika syndrome (CZS). The prevalence of this syndrome varies across ZIKV endemic regions, suggesting 
that its occurrence could depend on cofactors. Here, we evaluate the relevance of protein malnutrition for the 
emergence of CZS. Epidemiological data from the ZIKV outbreak in the Americas suggest a relationship between 
undernutrition and cases of microcephaly. To experimentally examine this relationship, we use immunocompetent 
pregnant mice, which were subjected to protein malnutrition and infected with a Brazilian ZIKV strain. We found 
that the combination of protein restriction and ZIKV infection leads to severe alterations of placental structure and 
embryonic body growth, with offspring displaying a reduction in neurogenesis and postnatal brain size. RNA-seq 
analysis reveals gene expression deregulation required for brain development in infected low-protein progeny. 
These results suggest that maternal protein malnutrition increases susceptibility to CZS.
INTRODUCTION
By the end of 2015, a severe Zika virus (ZIKV) outbreak in the 
Americas was followed by a steep increase in primary microcephaly 
(1). The causal relationship between ZIKV and brain malformations 
was confirmed by in vitro studies showing that ZIKV exposure 
directly infects human neural progenitors (2, 3) and impairs the 
growth of three-dimensional differentiating cultures (3) while 
altering genes (2) and proteins related to cell cycle arrest (4). In 
vivo, vertical ZIKV transmission was modeled mainly by using 
immunocompromised mice, which are susceptible to this viral 
infection (5, 6). Severe reduction of brain size is considered the 
hallmark of what is now called the congenital Zika syndrome 
(CZS), a collection of developmental malformations associated 
with ZIKV’s congenital infection such as ventriculomegaly, cal-
cifications, corpus callosum agenesis, lissencephaly, and retinal 
abnormalities (7).
As with other STORCH (syphilis, toxoplasmosis, others, rubella, 
cytomegalovirus, and herpes virus) pathogens, ZIKV infection during 
pregnancy leads to birth defects in some but not all affected mothers. 
Approximately 6 to 12% of infected pregnancies will result in CZS 
(8). The distribution of CZS in human populations, however, is 
asymmetrical (9). In Brazil, which has reported ~95% of all CZS 
cases (1) and where ZIKV has severely affected multiple states, most 
occurrences of CZS (~75%) were found in the disadvantaged socio-
economic region of the Northeast (1, 10). Epidemiological surveys 
showed that, even within Northeastern communities, ZIKV-related 
microcephaly was most prevalent in those areas with the lowest 
socioeconomic status (11). Hence, cofactors are likely to play a key 
role in modulating ZIKV infection’s severity and the level of develop-
mental impairment.
Malnutrition is considered one of the most critical causes of 
immunodeficiency worldwide (12), as it can substantially increase a 
host’s susceptibility to an infection and amplify pathogenesis severity 
(13). An insufficient intake of protein can be a form of undernutrition 
and is a widespread problem in low-income populations, which have 
limited access to more expensive food components (14).
Here, by analyzing epidemiological data collected in Brazil 
from the ZIKV outbreak period, we found a significant prevalence 
of microcephaly in states where undernutrition is more frequent. 
To experimentally assess this correlation, we developed a mouse 
model using immunocompetent pregnant females, which were in-
fected with ZIKV at the peak of embryonic neurogenesis and were 
exposed to protein restriction before and during gestation. Using 
this undernourished mouse model, we identified that there is 
robust and persistent ZIKV infection in the spleens of under-
nourished mothers, in contrast to controls. We also found severe 
alterations of placental structure and embryonic body growth 
compromise in addition to the decline of embryonic neurogenesis 
and reduction in brain size of newborns. From RNA sequencing 
(RNA-seq) analysis, we conclude that the significant differences in 
the regulation patterns of key pathways and particular genes iden-
tified within developing brains reflect how a poor nutritional 
status increases the adverse effects of ZIKV infection. Together, 
these data provide important new clues to understand the impact 
of environmental cofactors and, particularly, nutrition in the 
emergence of CZS.
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RESULTS
Microcephaly during ZIKV Brazilian outbreak is more 
prevalent in regions where undernutrition is endemic
First, we explored the potential relationship between undernutrition 
and microcephaly associated with ZIKV through correlation analysis 
using the Brazilian Ministry of Health’s integrated data bank. We 
focused on those states that occupied the tropical part of the country 
(24 of the 27 Brazilian states) since ZIKV has been more frequent 
there because of the abundance of its main vector, the Aedes mos-
quitoes. To study the hypothesized relationship, we then considered 
the number of cases of microcephaly that were confirmed and those 
still under investigation in the relevant states between 2015 and 2018 
and quantified the number of undernourished patients admitted to 
hospitals for the same states between 2009 and 2018. Considering 
this catchment area, a significant positive correlation was found to 
exist between cases of microcephaly and occurrences of under-
nourishment (r = 0.4, P = 0.05) (Fig. 1A). Since this correlation, 
although significant, is subtle, we used a probabilistic simulation 
approach to test whether the observed pattern is significant. The ob-
served correlation coefficient resulted in r = 0.4, and the P-adjusted 
value derived from the Monte Carlo simulation was 0.028 (fig. S1). 
In other words, this result supports the positive correlation identified 
between cases of microcephaly and undernutrition within the dataset, 
suggesting that states characterized by a higher number of cases with 
undernutrition over the past decade also exhibit more patients with 
microcephaly since the emergence of CZS in Brazil (Fig. 1A and 
table S1). Note that CZS cases are concentrated in some regions, 
although ZIKV infections were spread broader (fig. S2), confirming 
the asymmetrical geographical distribution previously reported (9).
To examine this association in more detail, we interviewed 83 
mothers of children with CZS from Ceará state (northeast of Brazil) 
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Fig. 1. Protein malnutrition reduces maternal body weight and enhances ZIKV load. (A) Relationship between undernutrition, measured as the number of hospital-
ized cases due to any undernutrition, and microcephaly cases that were confirmed or under investigation in Brazil since the first American ZIKV outbreak. Taking into 
consideration the data of 24 tropical states, a significant positive correlation was found between these variables (Pearson correlation: *r = 0.4, P-adj = 0.028). Each symbol 
represents a Brazilian tropical state. Geographical regions to which these states belong are indicated. hab, inhabitants. (B) Distribution of daily protein consumption of 
interviewed mothers with CZS children. Those that were under the recommended amount of protein intake are in gray, and those who achieved values above recommen-
dations are in black. Those mothers considered under protein restriction consumed 53.86 ± 5.49 g/day on average. Red lines indicate the daily average protein intake for 
the Northeast region (solid line) and particularly for the state of Ceará (dashed line). Mothers from Ceará have a mean protein intake significantly larger than CZS inter-
viewed mothers (t = −7.5, P < 0.001). (C) Schematic description of experimental groups and infection protocol. Wild-type dams were divided into control (Co) diet and 
low-protein diet (LP), and at E12, they were intraperitoneally injected either with 106 PFU of a Brazilian ZIKV strain from a stock with 3.4 × 106 PFU/ml (injected volume, 
295 l) or with the supernatant of Aedes albopictus C6/36 cells (Mock). P0, postnatal day 0. (D) Quantification of maternal body weight during pregnancy (n of dams per 
group: Co/Mock, 8; Co/ZIKV, 6; LP/Mock, 8; and LP/ZIKV, 11). Differences in maternal weight were only registered at E15 [Kruskal-Wallis, 11.375 (**)] [multiple comparisons 
with Mann-Whitney U: Co/Mock versus Co/ZIKV, Z = 0.000, Co/Mock versus LP/Mock, Z = −1.892; Co/Mock versus LP/ZIKV, Z = −2.522 (**); Co/ZIKV versus LP/Mock, 
Z = −2.027 (*); Co/ZIKV versus LP/ZIKV, Z = −2.720 (**); and LP/Mock versus LP/ZIKV, Z = −0.496]. Total leptin (E) and insulin-like growth factor 1 (IGF1) (F) maternal serum 
levels were measured by specific murine enzyme-linked immunosorbent assay (ELISA) at E15. The levels of both hormones were significantly lower only in LP groups than 
in Co diet groups [n per group: Co/Mock = 4; Co/ZIKV = 4 (leptin)/3 (IGF1); LP/Mock = 4; and LP/ZIKV = 3] [Kruskal-Wallis (leptin), 10.617 (*); multiple comparisons with 
Mann-Whitney U: Co/Mock versus LP/Mock, Z = −2.309 (*); Co/Mock versus LP/ZIKV, Z = −2.121 (*); Co/ZIKV versus LP/Mock, Z = −2.309 (*); and Co/ZIKV versus LP/ZIKV, 
Z = −2.121 (*)] [Kruskal-Wallis (IGF1), 9.967 (*); multiple comparisons with Mann-Whitney U: Co/Mock versus LP/Mock, Z = −2.309 (*); Co/Mock versus LP/ZIKV, Z = −2.121 
(*); Co/ZIKV versus LP/Mock, Z = −2.121 (*); and Co/ZIKV versus LP/ZIKV, Z = −1.964 (*)]. The error bar represents mean ± SD. (G) Viral load was quantified by RT-qPCR on 
E15 maternal spleen and expressed as ZIKV RNA copies per gram (n of dams per group: Mock = 4; Co/ZIKV = 4; and LP/ZIKV = 5). High levels of ZIKV RNA were found in 
most of LP/ZIKV spleen tissues [Mann-Whitney U: Co/ZIKV versus LP/ZIKV, Z = −2.147 (*)]. *P < 0.05, **P < 0.01, and P > 0.05.
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to indicate how many times a week they ate different types of foods. 
From these reports, the daily consumption of each macronutrient 
was estimated. We found that 37.35% of participants had a protein 
intake below 61 g/day (Fig. 1B and table S2), which is considered a 
protein-deficient diet for pregnant women (15). This is in agreement 
with previous studies that have identified the differential prevalence 
of maternal protein malnutrition in Brazilian regions such as the 
Northeast (27.3%) (16), the Southeast (12%) (17), and the South 
(2.85%) (18). Compared to data from the Brazilian Institute of 
Geography and Statistics [Instituto Brasileiro de Geografia e Estatística 
(IBGE)], on average, the protein intake in our sample is 64.14 g/day, 
lower than the reported state and regional values, 69.54 and ~71.00 g/day, 
respectively (Fig. 1B). The difference between the mean protein intake 
from the surveyed mothers of CZS babies and the reference for 
Ceará state is statistically significant (Fig. 1B). Furthermore, the 
overall distribution of protein intake levels in the survey is skewed 
toward lower levels. On the basis of these results, the relative risk 
was estimated by using the odd ratio formula, which compares the 
proportion of cases under or above the suggested protein intake of 
the interviewed mothers against that referenced by Ceará state. The 
resulting odd ratio of 1.5 indicates that there is a trend for CZS to be 
more probable in the protein-restricted group than in the well-nourished 
group of mothers (table S3). However, confidence intervals for the 
95% of the distribution are 0.96 to 2.34, and the odd ratio estimate 
(1.5) results in a marginally significant P value (0.07).
ZIKV infection results in higher viral load and reduced body 
weight in undernourished pregnant mice
To experimentally investigate the relationship between protein 
malnutrition and CZS, we used wild-type C57BL/6 females. These 
were either maintained on a standard mouse diet (Co) or shifted to 
a low-protein diet (LP) 7 to 10 days before mating and throughout 
gestation. At embryonic day 12 (E12), dams were injected intra-
peritoneally with 106 plaque-forming units (PFU) of Brazilian ZIKV 
or the supernatant of noninfected Aedes albopictus C6/36 cells, Mock 
(Fig. 1C). Dams did not differ significantly in body weight by E12, 
but LP mothers at 3 days post-infection (dpi) showed significantly 
less weight in comparison to control diet groups (table S4 and Fig. 1D). 
In particular, LP/ZIKV dams had significantly less body weight than 
Co/Mock and Co/ZIKV (P < 0.01), while LP/Mock significantly dif-
fered from Co/ZIKV (P < 0.05) (Fig. 1D). To confirm protein under-
nutrition, we measured levels of leptin and insulin-like growth factor 1 
(IGF1) in maternal serum at E15 through enzyme-linked immuno-
sorbent assays (ELISAs). As expected, both hormones showed signifi-
cantly lower levels in LP than in control diet groups (Fig. 1, E and F). 
To measure the maternal viral load, we processed spleen samples 
from the different groups and performed reverse transcription 
quantitative polymerase chain reaction (RT-qPCR) 3 dpi (Fig. 1G). 
LP/ZIKV maternal spleens showed increased viral load 3 dpi, while 
the virus was not detected in Co/ZIKV.
The placenta is affected after ZIKV and protein  
restriction exposure
As recent in vivo studies have shown that embryonic growth impair-
ment could be at least partly explained by the placental injury 
(6, 19–21), we examined some aspects of this organ in our mouse 
model at E15 (Fig. 2). Both infected groups displayed a similar pro-
portion of placentas with detectable viral RNA by RT-qPCR (Fig. 2B 
and fig. S3). ZIKV in the placental tissue was also localized using 
anti–nonstructural protein 1 (NS1) and anti–double-stranded RNA 
(dsRNA) (J2) antibodies. NS1 is present in both Co/ZIKV and LP/
ZIKV placentas, similar to the RT-qPCR analyses, although the ZIKV 
labeling is stronger in LP/ZIKV (fig. S4). Moreover, in LP/ZIKV 
placentas, J2-positive cells are colabeled with isolectin B4 (IB4), a 
marker of endothelial cells that, specifically in the placenta, reacts to 
labyrinth epithelial cells (fig. S5). In addition, negative strand–specific 
RT-qPCR assays were performed to quantify detectable replicative 
intermediate negative-strand RNA differences among the LP/ZIKV 
and Co/ZIKV groups. We found that LP/ZIKV placentas had a higher 
amount of negative-strand RNA than Co/ZIKV (fig. S5). Together, 
these results suggest that viral replication is higher in the placentas 
of the undernourished animals compared to control diet group.
At E15, some placentas showed abnormal labyrinth architecture: 
in the same blood space, both anucleated maternal red blood cells 
(RBCs) and nucleated embryonic RBCs were found (Fig. 2, A and C). 
This sign of vasculature damage was found in all the LP/ZIKV 
placentas (n = 9) and in a small portion (two placentas) of the total Co/
ZIKV (n = 8), while it was absent both in Co/Mock (n = 5) and LP/Mock 
(n = 5). Furthermore, conspicuous areas of necrosis in the labyrinth 
were found in 55.5% of LP/ZIKV placentas (Fig. 2D). This histo-
pathological feature was absent in the other groups (fig. S6). Last, 
we also found, in 44.4% of the LP/ZIKV placentas, hemorrhagic areas 
in the labyrinth, as illustrated in Fig. 2D. Together, cellular and 
molecular placental changes in LP/ZIKV indicate that a differential 
response is triggered in females when the effect of protein restriction 
diet and ZIKV infection are combined.
Embryonic body growth and neurogenesis is compromised 
by the interaction of protein malnutrition and ZIKV infection
The foregoing data demonstrate that maternal malnutrition associated 
with ZIKV infection impairs the placental structure. To determine 
whether the offspring development is affected in this context, we 
first analyzed morphological outcomes in embryonic life (E15). No 
significant differences were found in the size of the litters or the 
sporadic embryonic reabsorptions. As expected, we found that body 
weight at E15 is not compromised in noninfected LP pups (Fig. 3A). 
It is known that maternal protein undernutrition affects pup body 
weight only in later life (22). In contrast, ZIKV infection in the LP 
group results in a significant difference compared to the Co/Mock 
group (Fig. 3A). The body weight variance of LP/ZIKV displays a 
bimodal pattern, in which approximately half of the specimens 
showed growth restriction (Fig. 3A), statistically different when 
compared with the other groups (P < 0.001).
In addition to general growth restriction, we analyzed the viral 
load and morphological abnormalities in the E15 and E18 brains. 
RT-qPCR analysis of embryonic E15 brains revealed that both Co/
ZIKV and LP/ZIKV have detectable viral load (fig. S7). At E18, brains 
from Co/ZIKV and LP/ZIKV displayed comparable viral loads, 
although two LP/ZIKV specimens from the same litter presented 
higher ZIKV RNA levels than Co/ZIKV (fig. S7). Using immunocy-
tochemistry, we found colocalization of NS1+ cells with microglial 
ionized calcium-binding adapter molecule 1 (Iba1+) cells and endothelial 
CD31+ cells in the E15 brain both of Co/ZIKV and LP/ZIKV (figs. S8 
and S9). However, abundant macrophage/microglia cells (Iba1+ cells) were 
found especially in the lateral ventricles of the LP/ZIKV group (Fig. 3B), 
reflecting a local response to congenital infection. ZIKV-infected cells 
(J2+) are found in LP/ZIKV specimens colocalized with IB4+ cells, a marker 
of endothelial and microglial cells in the brain (23) within the ventricular 







Barbeito-Andrés et al., Sci. Adv. 2020; 6 : eaaw6284     10 January 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
4 of 12
zone (fig. S10). The ventricular and subventricular zones are also known 
as the proliferative zone in the developing cerebral cortex. To address 
whether maternal malnutrition and ZIKV infection affect neuro-
genesis, we examine proliferation with an antibody against anti-Ki67 
to identify progenitors that were in any phase of the replicative cycle. 
These cycling progenitors (Ki67+) in the cortical proliferative zone of 
E15 were reduced in the LP/ZIKV experimental group in comparison 
to the other groups (Fig. 3C). Accordingly, the early-born infragranular 
neurons [as identified by COUP-TF-interacting protein 2 (CTIP2) 
antibody], which will occupy the layer V in the postnatal cortex, 
were also reduced in the developing cortical plate (Fig. 3D).
ZIKV infection modulates gene expression in the developing 
brain of malnourished pups
To determine the differential gene expression related to the de-
scribed embryonic phenotypes, we performed RNA-seq analyses in 
E15 brains. The combination of protein restriction and ZIKV pro-
duced large deregulation, particularly in genes involved in cell cycle 
control, mitotic progression, and neural development (Fig. 4A). Using 
a Circos plot analysis, we found 60 key clusters, indicating that a 
small number of hub genes deregulate a large number of genes in 
CZS (Fig. 4B). A critical pathway in neural stem cell proliferation, 
neuron differentiation and assembly, and maintenance of neural cir-
cuits, the mammalian target of rapamycin (mTOR) signaling pathway, 
is deregulated in LP/ZIKV (fig. S11). Beyond changes of entire 
pathways, specific key genes exhibited interesting patterns. For in-
stance, genes related to neural development—such as Ncam2, 
Shank1, and Icam5—were down-regulated in LP/ZIKV (Fig. 4C). 
Moreover, Kir3dl2, a receptor located at the surface of natural killer 
cells and Cd46, which participates in T cell activation, were also down- 
regulated in LP/ZIKV (Fig. 4C). In contrast, we found important 
genes involved in antiviral (e.g., Rps3 and Ccr1) and inflammatory 
Fig. 2. Placental alterations 3 days after ZIKV infection in LP group. (A) Schematic representation of a placental structure. Normal labyrinth structure is characterized 
by separate maternal sinus with anucleated erythrocytes and embryonic capillaries with nucleated blood cells. (B) Viral load in the placentas was quantified by RT-qPCR 
(n per group E15: Mock = 13; Co/ZIKV = 10; and LP/ZIKV = 11; placentas were derived from five independent litters in each group). Lines indicate the geometric mean. 
Detectable viral RNA was found in 40% of Co/ZIKV placenta and in ~50% of LP/ZIKV placentas. No statistically significant difference in the amount of viral RNA was detected 
between means of Co/ZIKV and LP/ZIKV (P > 0.05). (C) Analysis of placental sections with hematoxylin and eosin (H&E) staining. Representation of altered labyrinth mor-
phology with nucleated (embryonic, arrow) and anucleated (maternal, arrowheads) blood cells sharing the same vascular spaces found in LP/ZIKV placentas is shown. 
Scale bar, 20 m. (D) Necrotic areas were identified in the spongiotrophoblast of some LP/ZIKV cases (top), with abundant examples of pyknosis and karyorrhexis, suggesting 
the occurrence of this degenerative process. In addition, an example of the hemorrhagic area found in the LP/ZIKV labyrinth is shown (bottom). White frames were used 
to indicate the location of the lesion. Scale bar, 50 m.
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response (e.g., Il16 and C1qtnf9) that were up-regulated in LP/ZIKV, 
as well as genes that modulate apoptotic mechanisms, such as Cdk1 
and Plk1 (Fig. 4D).
Neonates from undernourished and infected dams have 
reduced brain size
To understand whether those changes observed during embryonic 
life result in postnatal differences compatible with phenotypes de-
scribed in CZS, we investigated postnatal offspring growth (Fig. 5). 
In neonates, body weight was significantly reduced in LP/ZIKV (Fig. 5C), 
while brain size was also impaired (Fig. 5, A, B, and D). Brains re-
constructed using micro–computed tomography (CT) revealed the 
microcephaly phenotype-like only in the LP/ZIKV litters (Fig. 5A). 
Cerebral cortex sections counterstained with DAPI (4′-6-diamidino- 
2-phenylindole) showed a reduction in the correspondent cortical 
wall area of this group when compared with the other controls 
(Fig. 5B). We found that LP/ZIKV brains were significantly smaller 
than those of the other groups (Fig. 5D). Since body weight and 
brain size are affected in LP/ZIKV, we examined whether brain size 
in this group corresponds to that expected for its body size. Using a 
linear regression between brain size and body weight, negative 
residuals were obtained for LP/ZIKV, indicating that brain size is 
relatively more affected than body weight in this group (fig. S12). 
In addition, morphometric analyses revealed that the cortical size is 
relatively more affected than the other brain areas in the LP/ZIKV 
group (Fig. 5E). We also assessed differences in skull size and found 




































































































Fig. 3. Maternal undernutrition associated with ZIKV during pregnancy results in neurodevelopmental impairments 3 days after infection (E15). (A) Quantifica-
tion of body weight of embryos at E15 [Kruskal-Wallis, 8.360 (*); multiple comparisons with Mann-Whitney U: Co/Mock versus LP/ZIKV, Z = −1.959 (*)]. Variance is signifi-
cantly different between groups, as estimated by Bartlett test K-squared, 19.929 (***). (B) Analysis of microglia/macrophage recruitment with Iba1+ immunostaining (red) 
reveals the presence of reactive cells in the developing brain of LP/ZIKV group, in particular, in the lateral ventricles. (C) Immunostaining and quantification of cycling cells 
in the proliferative zone show a reduction of Ki67+ cells (green) in LP/ZIKV cortex. Analysis of variance (ANOVA) F = 3.838 (*); least significant difference (LSD): Co/Mock 
versus LP/ZIKV (*) (P-adj > 0.05), Co/ZIKV versus LP/ZIKV (*) (P-adj > 0.05), LP/Mock versus LP/ZIKV (*) (P-adj > 0.05), df = 3. DAPI, 4′-6-diamidino-2-phenylindole. (D) Immuno-
staining and quantification of early-born neurons labeled with CTIP2+ (green). LP/ZIKV results in a reduction in cortical neurons compared with controls. ANOVA F = 4.77 (*); LSD: 
Co/ZIKV versus LP/ZIKV (*) (P-adj > 0.05), LP/Mock versus LP/ZIKV (**) [P-adj < 0.05 (**)], df = 3 (n = 3 per each group; in all cases, three sections of each brain were quanti-
fied and averaged). *P < 0.05 and **P < 0.01. The error bar represents mean ± SD. Scale bars, 50 m.
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DISCUSSION
Although ZIKV is only responsible for mild symptoms in most adult 
cases, the recent experience in the Americas has alarmed the bio-
medical community because of a sudden increase in congenital 
abnormalities caused by this viral infection. Since CZS is distributed 
heterogeneously, cofactors could play a role in this asymmetrical 
pattern (9). Recently, it was suggested that fetal genetic background 
could predispose to malformation development after ZIKV vertical 
transmission (8). Beyond genetic predisposition, it was shown that 
environmental factors, such as the previous exposure to dengue virus, 
increase susceptibility to ZIKV congenital infection and lead to more 
exacerbated phenotypic alterations in the brain (24). Since immune 
status also depends on nutritional conditions, these are crucial elements 
to understand differential infection outcomes (13). Here, we identify 
the effect of nutritional restriction on CZS development.
First, we found that there is a positive correlation between regions 
with a high index of undernourished patients and regions with a 
high incidence of microcephaly cases registered during the ZIKV 
outbreak in Brazil. Furthermore, we interviewed mothers of CZS 
children and observed a reduced protein intake in approximately 
40% of them. In comparison to the state and regional protein intake 
average, CZS mothers show a significant protein restriction. More-
over, the values obtained in our sample of CZS mothers differ from 
previously published references for pregnancies in other regions of 
Brazil (16–18). It has been reported that CZS is more prevalent in 
low-income populations (9, 11). Nutritional impairment has been 
found to result in the compromise of several innate and adaptive 
pathways of the immune system (25–28). Mainly, protein restriction is 
an issue in those vulnerable populations with limited access to more 
expensive food components (14). Together, on the basis of our data 
and previous studies, we propose that nutritional status could, at 
least partially, contribute to the asymmetrical prevalence of CZS.
The link between malnutrition and CZS was further investigated 
in vivo with wild-type mice (fig. S14). Different reports have found 
that adult wild-type mice under normal conditions are not very efficient 
in replicating and vertically transmitting ZIKV (6, 29), and conse-
quently, a large part of the research modeling ZIKV infection 
in vivo used immunocompromised animals (6, 19, 29, 30). Although 
vertical transmission of ZIKV is detected in some wild-type mice, 
these animals do not model the primary microcephaly associated 
with ZIKV infection (31), suggesting that disparities among models 
might depend on the particularities of the experimental designs such 
as ZIKV virus strain, amount of inoculated PFUs, and time between 
inoculation and harvesting, among others. Here, immunocompetent 
mice were used, allowing us to explore CZS in a context that better 
reflect pathophysiological responses in humans. We found that 
wild-type female mice exposed to protein restriction exhibit an in-
creased viral load in the maternal spleens 3 days after infection. Pre-
vious work has also shown that adult wild-type C57BL/6J females 
infected with ZIKV intraperitoneally are capable of clearing the circu-
lating virus in the first dpi (32). These results indicate that LP animals 
did not eliminate the circulating virus as soon as well-nourished 
animals, suggesting that antiviral response may be compromised in 
malnutrition. Differences in the maternal response to viral infection 
between Co/ZIKV and LP/ZIKV could reflect variations in the 
immunological maternal status, which might have an impact in the 
developing embryos. It has been described that ZIKV preferably 
replicates at the placenta (21). In our study, placentas from both 
infected groups (LP/ZIKV and Co/ZIKV) had comparable viral loads 
for total RNA detections, as measured by RT-qPCR. However, 
immunohistochemistry labeling using anti-J2 (dsRNA) and anti-NS1 
antibodies as well as PCR analyses on replicative intermediate 
negative-strand RNA suggest that there are differences regarding 
viral replication of ZIKV between Co and LP infected groups.
Placental damage caused by ZIKV has been proven to be an impor-
tant contributor to embryonic and fetal growth restriction (6, 19–21). 
Vasculature damage signatures in the placenta of malnourished and 
infected cases are comparable to what is described in other in vivo 
models of ZIKV vertical transmission (19, 33). Moreover, necrotic 
areas found in the labyrinth reflect severe pathological processes 
Fig. 4. LP and congenital ZIKV infection induce gene expression deregulation in embryonic brains. (A) Pathways reflecting biological processes that are deregulated 
in the LP/ZIKV in comparison to Co/ZIKV after RNA-seq analyses. Only those with large significant differences are presented. (B) Circos plot showing the 60 hub genes, 
most (red) and least (blue) expressed in LP/ZIKV (in comparison to Co/ZIKV) shared between relevant cellular processes. Individual selected genes that are significantly 
down-regulated (C) or up-regulated (D) in LP/ZIKV in comparison to Co/ZIKV. FC, fold change.
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occurring in this organ. Analysis of the LP/ZIKV placenta indicates 
that a differential local response is triggered at E15, shortly after the 
infection, at E12, with concomitant structural alterations. In contrast, 
immunocompetent dams infected with ZIKV earlier, at E9.5, also 
display structural placental damage after 4 dpi (21). Thus, these re-
sults point out that the severity of the placental impairment resulting 
from ZIKV infection depends on the embryonic stage of infection 
and the harvesting time point. This placental damage could be 
essential to understand some features of growth impairment in the 
offspring that not only result from direct embryonic infection but 
also indirect pathogenic mechanisms. In sum, we agree on the 
importance of placental insufficiency effects in the emergence of 
CZS beyond direct fetal infection (19–21).
Associated with a differential maternal response to ZIKV infec-
tion and placental damage, we found phenotypic changes in the 
LP infected group comparable to previous descriptions of CZS 
both in humans and in animal models: intrauterine growth re-
striction, placental injury, impaired neurogenesis, and local inflamma-
tion (5, 7, 34). Body weight reduction is a clear sign of intrauterine 
growth restriction, a condition that was described as part of CZS in 
humans (7, 34, 35) and mouse models (5, 6). Recently, a survey showed 
that the prevalence of low birth weight is four times higher in CZS 
children compared to other newborns from the same region (36). In 
our assays, we found body weight reduction in infected malnourished 
litters, consistent with the findings in human CZS cases. A recent 
study on wild-type C57BL/6J mice have found that vertical trans-
mission of ZIKV after intraperitoneal injection on pregnant females 
does not result in morphological alterations in the offspring during 
perinatal life but negative outcomes appeared later in postnatal life 
(31). This coincides with our results of Co/ZIKV in which we con-
firmed ZIKV congenital infection, but we did not find phenotypic 
signals of CZS in embryos and neonates. Since structural alterations 
were found here during prenatal and early postnatal life in the 













































































Fig. 5. LP mediates brain size reduction after ZIKV. (A) Representative three-dimensional reconstructions of brain anatomy of neonates obtained from CT illustrate 
size reduction in the LP/ZIKV group. Scale bar, 1 mm. (B) Coronal histological DAPI-stained sections also illustrate a cortical wall reduction (scale bar, 0.25 mm). The white 
measurement indicates the cortex thickness in the Co/Mock group, illustrated with the same size in all the other groups for comparative purposes. (C) Quantification of 
total body weight of newborns shows a significant decrease in the LP/ZIKV weight at P0. Kruskal-Wallis, 17.217 (***); multiple comparisons with Mann-Whitney U: 
Co/Mock versus Co/ZIKV, Z = −1.724; Co/Mock versus LP/Mock, Z = −1.328; Co/Mock versus LP/ZIKV, Z = −3.634 (***); Co/ZIKV versus LP/Mock, Z = −0.216; Co/ZIKV versus 
LP/ZIKV, Z = −2.621 (**); and LP/Mock versus LP/ZIKV, Z = −1.857. (D) Brain centroid size (CS), the square root of the summed squared distances of all digitized points to 
the centroid of the configuration, was obtained after the digitization of the three-dimensional position of 57 anatomical points. Kruskal-Wallis, 22.541 (***); multiple 
comparisons with Mann-Whitney U: Co/Mock versus Co/ZIKV, Z = −0.707; Co/Mock versus LP/Mock, Z = −1.768; Co/Mock versus LP/ZIKV, Z = −3.158 (**); Co/ZIKV versus 
LP/Mock, Z = −1.609; Co/ZIKV versus LP/ZIKV, Z = −2.982 (**); and LP/Mock versus LP/ZIKV, Z = −3.530 (***). (E) The proportion of cortex centroid size in relation to total 
brain centroid size. This proportion in LP/ZIKV group is smaller than in undernourished pups that have not been infected with ZIKV. Kruskal-Wallis, 13.743 (**); multiple 
comparisons with Mann-Whitney U: Co/Mock versus Co/ZIKV, Z = −0.354; Co/Mock versus LP/Mock, Z = −1.768; Co/Mock versus LP/ZIKV, Z = −2.216 (*); Co/ZIKV versus LP/Mock, 
Z = −2.082 (*); Co/ZIKV versus LP/ZIKV, Z = −1.765; and LP/Mock versus LP/ZIKV, Z = −3.043 (**). *P < 0.05, **P < 0.01, ***P < 0.001, and P > 0.05. The error bars represent 
means ± SD.
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contributes to the negative outcomes on ZIKV congenitally infected 
specimens.
The devastating consequences of ZIKV infection in developing 
nervous systems were previously linked to its tropism for immature 
neural cells (3). Here, embryonic macrophagic cells in the brain co-
localized with ZIKV. A previous in vitro study showed that microglia 
cells are also a ZIKV target (37). Thus, neuroinflammation could play 
a key role in the pathogenesis of CZS. In this neuropathological 
context, we described impairment of the neurogenesis and cortical 
development pre- and postnatally. The cerebral cortex is relatively 
more affected in LP/ZIKV than other brain structures, similar to what 
is described in human CZS (34). To molecularly understand those 
effects on brain development associated with malnutrition and ZIKV 
infection, we performed RNA-seq. Comparing the group where in-
fection was combined with nutritional restriction, the control diet 
infected animals resulted in altered molecular pathways related to 
cell cycle, viral replication, DNA damage, and inhibition of neuro-
genesis. This largely coincides with those deregulated pathways in 
the 3-day in vitro ZIKV-infected neurospheres (4). More specifically, 
because of ZIKV infection following undernutrition, some genes, 
such as Cd46, relevant to immune response are down-regulated, and 
proinflammatory response genes, such as Il6, are up-regulated. Several 
genes required for normal brain development, like Shank1 and 
Ncam2, are down-regulated in LP/ZIKV, indicating that specific 
processes leading to neural growth and patterning are impaired. 
Besides, the mTOR signaling pathway, significant for neural develop-
ment, is deregulated. Similarly, a previous report also found alterations 
of this pathway in CZS human twins (8).
Malnutrition is one of the most frequent causes of increased sus-
ceptibility to infectious disease (12, 13) and is a widespread problem 
in low-income populations (38). Our experimental approach 
provides a framework for investigating the interaction of malnutri-
tion and ZIKV in vivo. We have found that protein restriction me-
diates ZIKV infection and exacerbates developmental impairment 
in the offspring, suggesting that the nutritional status of the dam can 
be a determining factor in differential susceptibility to CZS. ZIKV 
infection is a complex pathological process in which the magnitude 
of the congenital abnormalities is not only associated with the viral 
load in each tissue; indirect factors such as placental damage can 
also play important roles in development of these abnormalities 
(19, 21). To deepen current knowledge on the emergence of CZS, it 
is essential to understand the cofactors modulating previous outbreaks, 
thus improving preventive measurements facing future epidemics.
MATERIALS AND METHODS
Epidemiological analyses on Brazilian cases  
of microcephaly and undernutrition
First, data were obtained from the Brazilian Ministry of Health via 
the integrated data bank RESP (Registro de Eventos em Saúde 
Pública/Public Health Events Registry) to quantify the total amount 
of cases of microcephaly that were confirmed and reported still 
under examination between 2015 and 2018. This amount was stan-
dardized by 1000 inhabitants. The total number of patients hos-
pitalized by any type of undernutrition between 2009 and 2018, 
normalized by 1000 inhabitants, were extracted from the Brazilian 
Ministry of Health public data bank CID-10 (Classificação Estatística 
Internacional de Doenças e Problemas Relacionados à Saúde/
International Statistical Classification of Diseases and Related Health 
Problems) available at www.datasus.gov.br/cid10/V2008/cid10.htm. 
Undernutrition was defined by the health agents as cases diagnosed 
and satisfying at least one of the following conditions: kwashiorkor, 
nutritional marasmus, severe calorie-protein undernutrition, moderate 
to mild calorie-protein undernutrition, growth retardation due to 
calorie-protein undernutrition, and nonspecified calorie-protein 
undernutrition. For the definition of these categories, which were 
codified as E40-46 in the CID-10 public bank, the criteria defined 
by the World Health Organization were applied. A decade’s worth 
of data regarding hospitalization due to undernutrition was taken to 
have a more consistent description of this variable. The coefficient 
of variation for the raw number of patients hospitalized by under-
nutrition over these years ranged between 2.00 for the state of Sergipe 
and 11.15 for the state of Espirito Santo. To avoid sampling bias, 
municipals with less than 20,000 inhabitants were excluded. Values 
for both variables (microcephaly and undernourishment) were ob-
tained for all tropical states in the Northeast, North, Central-West, 
and Southeast regions. A Pearson correlation analysis was performed, 
and a simple linear regression was also carried out to assess the 
association between both variables. After obtaining a P value under 
the assumptions of a parametric test for this correlation, a simulation 
approach was used to estimate the significance of the correlation using 
a Monte Carlo permutation analysis. For this purpose, the values 
from our original sample were randomly correlated (999 times), and 
the frequency of each r coefficient was registered and illustrated in 
fig. S1. Then, by comparing our original r coefficient in the simulated 
distribution, it was possible to detect how probable our correlation 
to occur by chance is, and an adjusted P value was derived.
In addition, a survey on a sample of mothers who have children 
with CZS was performed in the Northeastern state of Ceará. We 
interviewed 83 affected mothers, and a diet frequency questionnaire 
was completed, in which we asked the number of times they ate 
different categories of foods per week. Data that support this part of 
the study are available on request from the corresponding author 
(P.P.G.). Ethical approval was obtained for data collection in protocol 
2385592 from the Federal University of Ceará. On this basis, we 
quantified the amount of daily protein consumption by multiplying 
the daily frequency of consumption of each food by the protein con-
tent of this food in a standard portion. The total daily protein intake 
was obtained by summing these values for the consumed foods, as 
described by Rogers and Emmett (39). According to current recom-
mendations, the average consumption of protein during pregnancy 
should be above ~60 g/day (www.nrv.gov.au/nutrients/protein). 
We subsequently quantified the number of cases where consump-
tion was either below or above 61 g/day to have an estimation of the 
portion of the sample affected by low protein intake.
The pattern of protein intake obtained from the interviewed 
mothers was compared with a reference for the state of Ceará and 
the whole Northeast region. For this purpose, we used the “Survey 
of familiar incomes 2008-2009” (Pesquisa de orçamento familiares 
2008-2009) database of the IBGE and depicted the average values 
for Ceará and the Northeast together with the histogram of our 
sample. For Ceará state, the average value of protein intake was es-
timated from the data on the frequency of consumption of different 
foods, while the value of daily protein intake for the entire North-
eastern region is available in the IBGE data bank by age and sex. In 
this case, the protein intake of women between 19 and 59 years was 
taken as a reference. In addition, we statistically compared the 
means of our sample and reference of Ceará for the variable daily 
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protein intake using a t test. Similarly, we estimated the relative risk 
of CZS in relation to the protein intake level. Since our condition (CZS) 
had low frequency in the population, we carried out the analyses under 
“the rare disease assumption” and estimated the odd ratio (40). Given 
that the frequency of CZS is rare in the population, reference data 
for Ceará can be considered as representative of the protein intake 
of a non-CZS group.
Experimental design: Diet and infection
C57BL/6 nulliparous female 6-week-old mice were obtained from the 
Animal Care Facility of the Microbiology Institute of the Federal 
University of Rio de Janeiro. They were divided into two groups 
according to the consumed diet. Control females were fed a standard 
diet with the recommended amount of macro- and micronutrients 
(TD91352, Harlan Teklad, Madison). In the control diet, protein 
content was 20.3%. In contrast, the LP group received a diet with 
6.1% of protein in the form of casein and dl-methionine. These diets 
are isocaloric (3.8 kcal/g), having the same percentage of fat (5.5%) 
and a different proportion of carbohydrates (control, 61.6%; LP, 75.6%).
Administration of both diets started 7 to 10 days before mating 
and continued until the harvesting dates. Animals had ad libitum 
access to water and food. Throughout the whole experiment, we 
assessed food intake daily. No significant differences between groups 
were found regarding the amount of consumed food. Females were 
housed in single cages throughout the whole experiment. Pregnancy 
was confirmed through observation of the postcoital vaginal plug to 
have an accurate estimation of embryonic age.
On E12, we performed intraperitoneal injections in control and LP 
dams of ZIKV (infected) or Mock (noninfected). Dams were injected 
with 106 PFU of a Brazilian ZIKV strain obtained from a patient 
presenting typical symptoms of ZIKV infection (Recife/Brazil, 
ZIKV PE/243, accession no. KX197192.1) (41). For experimental 
comparisons with noninfected animals, we injected control and 
LP dams with the supernatant of A. albopictus C6/36 cells (Mock). 
The viral titer of the stock was 3.4 × 106 PFU/ml, and the injected 
volume was 295 l. These treatments yielded four experimental groups: 
control/Mock (control diet, noninfected), control/ZIKV (control diet, 
ZIKV infected), LP/Mock (LP, noninfected), and LP/ZIKV (LP/
ZIKV infected). Harvesting of samples was carried out during em-
bryonic life in E15 and on the first day of postnatal life (P0). In the 
case of E15 sample harvesting, dams were culled using cervical dis-
location. Neonates at P0 were decapitated. Embryos and neonates 
were weighed on a standard laboratory scale with a definition of 1 mg 
(OHAUS, USA) before decapitation.
Weight in E15 embryos was measured in specimens of each litter 
giving a total sample of n = 33 (Co/Mock), n = 33 (Co/ZIKV), n = 27 
(LP/Mock), and n = 50 (LP/ZIKV). For Co/Mock, five independent 
litters in E15 were used (number of embryos for each litter = 3, 7, 7, 
8, and 8), while for the Co/ZIKV embryos, weights derived from six 
independent litters (number of embryos for each litter = 2, 3, 5, 6, 8, 
and 9) were measured. For LP/Mock, four independent litters were 
used (number of embryos for each litter = 5, 7, 7, and 8), and last, in 
LP/ZIKV, embryos from seven litters were weighed (number of 
embryos for each litter = 5, 6, 6, 6, 8, 9, and 10). In P0, we reported 
body weights from those specimens that were CT-scanned to obtain 
brain size (Co/Mock, n = 9 neonates from three independent litters; 
Co/ZIKV, n = 6 neonates from two independent litters; LP/Mock, 
n = 6 neonates from three independent litters; and LP/ZIKV, n = 20 
from four independent litters).
ZIKV was propagated in C6/36 cells. Briefly, C6/36 cells were 
infected at a multiplicity of infection of 0.01 and incubated at 
37°C. After 1 hour, the inoculum was removed and replaced with 
growth media supplemented with 2% fetal bovine serum. After 
6 days, the conditioned medium was harvested, centrifuged at 300g, 
and filtered through 0.22 m to remove cells and cellular debris. 
Supernatants were collected and stored at −80°C. Virus titers were 
determined by plaque assay performed on Vero cells.
All animals used in this study were housed in the Animal Care 
Facility of the Microbiology Institute of the Federal University of 
Rio de Janeiro. All procedures were approved by institutional ethical 
committee, protocol CEUA-CCS/UFRJ 01200.001568/2013-87.
Viral detection
RNA was extracted from maternal spleen, placentas, and embryonic 
brains using the TissueRuptor (IKA) and the RNeasy Plus Mini Kit 
(QIAGEN), following the recommendations of the manufacturer. 
To quantify viral RNA, we used One Step TaqMan RT-qPCR (Thermo 
Fisher Scientific) on a 7500 Real-Time PCR System (Applied Bio-
systems) with primers and probe described by Lanciotti et al. (42). 
ZIKV copies were determined by interpolation onto a standard curve 
composed of eight 10-fold serial dilutions of a synthetic ZIKV RNA 
based on the Asian lineage. The ZIKV quantification was expressed 
as ZIKV RNA copies per gram of tissue. For maternal spleens 3 dpi, 
the sample size was 4 for Mock, 4 for Co/ZIKV, and 5 for LP/ZIKV. 
In addition, in E15 placentas, the sampling included organs from 
five independent litters for each group. Numbers of placentas of each 
litter within each group were as follows: Mock = 1, 1, 2, 3, and 6 
(n = 13); Co/ZIKV = 1, 1, 2, 3, and 3 (n = 10); and LP/ZIKV = 2, 2, 
2, 2, and 3 (n = 11).
For the specific negative-strand RNA detection, total RNA from 
tissue samples was purified with the RNeasy Plus Mini Kit (QIAGEN), 
following the manufacturer’s recommendations. Reverse transcrip-
tion was performed with the High-Capacity cDNA Reverse Tran-
scription Kit (Thermo Fisher Scientific) using only forward primers 
(ZIKV 1086) for the specific retrotranscription of the negative strand 
of viral RNA. Subsequently, qPCR was performed using the ZIKV 
PrimeTime assay (IDT) on the GoTaq Probe qPCR System (Promega). 
A standard curve provided by serial dilutions of ZIKV synthetic RNA 
was used for absolute quantification.
Measurements of hormones in maternal serum
Systemic levels of IGF1 and leptin were assessed in maternal serum 
using the following kits: Abcam ab100695 and a100718. The proce-
dures were carried out according to the manufacturer’s suggestions. 
In these analyses, serum from three to four dams of each group was 
analyzed at E15.
Immunostaining and imaging analyses of embryonic brain
Brains of E15 embryos were fixed with 4% paraformaldehyde (Sigma- 
Aldrich, USA) overnight and then embedded in 30% sucrose to 
provide cryoprotection to the tissue. Coronal sections (10 m) were 
obtained with a cryostat (Leica, Germany), permeabilized with 0.1% 
Triton X-100 (Sigma-Aldrich, USA), and incubated with 3% bovine 
serum albumin (Sigma-Aldrich, USA). After standard antigenic re-
trieval, the following primary antibodies were incubated overnight: 
mouse J2 anti-dsRNA I (1:500), rat anti-CTIP2 (1:500; Abcam, ab18465), 
rabbit anti-Ki67 (1:100; EMD Millipore, AB9260), mouse anti-Iba1 
(1:200; EMD Millipore, MABN92), rabbit anti-Iba1 (1:500 Wako 
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Chemicals USA Inc.), and rabbit anti-CD31 (Abcam, ab28364). 
Subsequently, samples were washed with phosphate-buffered saline 
(PBS) and incubated with secondary antibodies: goat anti-mouse 
Alexa Fluor 488 (1:500; Abcam, ab150113), goat anti-rat Alexa Fluor 
488 (1:500; Abcam, ab150157), and goat anti-mouse Alexa Fluor 546 
(1:500; AP192SA6) (Thermo Fisher Scientific, USA). In those sections 
where IB4 (1:50; Vector Laboratories, FL1201) was used, it was in-
cubated with secondary antibodies for 2 hours. Nuclei were stained 
with DAPI (0.5 g/ml) for 20 min. Images were acquired with a TCS 
SP8 confocal microscope (Leica, Germany) and a laser scanning 
confocal microscope (Olympus FV1000, Japan) with 20×, 40×, or 
63× objective high numerical apertures.
In all cases, at least three brains of each experimental group were 
examined and analyzed. Brains in each group belong at least to two 
different litters. For each brain, three consecutive sections were 
analyzed, and an average of their results was taken as the representative 
value for the specimen. All data collection was performed by one of 
the authors (J.B.-A.) using a blinding code. Previous to definite data 
collection, we analyzed intraobserver repeatability in a subsample of 
images and confirmed consistency in marker identification. Analyses 
of the acquired images were carried out using Fiji software (43). We 
performed a quantitative analysis based on the work by Wu et al. 
(32) where the band thickness of positive-stained cells was analyzed. 
Here, we measured the distance between the ventricular limit and 
the most upper located Ki67+ cells. For CTIP2 staining, we counted 
the absolute number of cells that were positive in an area with a 
height of 100 m and a width of 70 m.
Placenta histology
For hematoxylin and eosin (H&E) staining, placentas were embedded 
in paraffin blocks and sectioned at 5 m after overnight fixation in 
4% paraformaldehyde. On these sections, a qualitative observation 
was carried out to examine the general structure of decidua and 
labyrinth regions. Fluorescent staining on placentas was performed 
on frozen sections of 10 m obtained from cryostat. Sections were 
prepared with the same protocol used for brain immunostaining 
and were incubated overnight with mouse anti-J2. After PBS wash, 
sections were incubated with goat anti-mouse Alexa Fluor 546 
(1:500; AP192SA6) (Thermo Fisher Scientific, USA) and IB4, an 
isolectin for vasculature staining. In addition, we used a mouse 
anti-NS1 antibody (1:100; EA88) (Thermo Fisher Scientific, USA) 
to detect ZIKV in the placenta. Following incubation of the primary 
antibody, a goat anti-mouse Alexa Fluor 488 (1:1000, A28175) 
(Thermo Fisher Scientific, USA) was used.
Total RNA-seq
Total RNA was isolated from brains of E15 embryos using TRIzol 
(Invitrogen) protocol, followed by an analysis of quality with Bio-
analyzer (Agilent) and quantity Qubit (Invitrogen). Subsequently, 
those samples were submitted to library construction using TruSeq 
Stranded mRNA HT Sample Prep Kit (Illumina), in which mRNA 
is enriched across magnetic beads with oligo(dT). This enriched mRNA 
template is converted to double-stranded cDNA, followed by AMPure 
XP bead purification, end repair, and A-tail addition. For each sample, 
an index was associated, and so, the library was amplificated by PCR 
to enable cluster generation for sequencing at HiSeq 2500 (Illumina). 
The RNA-seq data were mapped to the Genome Reference Consortium 
Mouse Build 38 (GRCm38–mm10) with STAR 2.5.4b algorithm (44) 
after count tables for each gene was generated by HTSeq. The differ-
ential expression of genes was done in edgeR package. Gene Ontology 
enrichment analysis was performed with the R package GAGE 2.3. 
From the list of differentially expressed genes (P < 0.05 and log fold 
change, ≤−1 or ≥1), we performed gene set enrichment analysis 
using ensemble of gene set enrichment analyses and derived a 
protein-protein interaction network with NetworkAnalyst.
A list of differentially expressed genes is available in table S5. For 
validation, five differentially expressed genes were selected from 
Fig. 4 (C and D) and analyzed by RT-qPCR (Ccr1, Shank1, Galr1, 
Grin1, and Slc6a7). For this purpose, purified RNA samples were 
submitted to retrotranscription followed by qPCR reaction in a 
one-step reaction protocol. The constitutive gene used was GAPDH, 
which showed good performance in mice in E15 (45). Results of 
relative expression were expressed by 2CT. We used the GoTaq 
1-Step RT-qPCR System (Promega) for Ccr1 and Shank1, and for 
quantification of Galr1, Grin1, and Slc6a7, the LightCycler 480 System 
(Roche Life Sciences) was used. Results are presented in fig. S15.
CT and morphometric analysis
CT of the brains and skulls were performed at P0. Images were 
obtained using a Bruker SKYSCAN 1173 CT scanner. To obtain 
skull images, neonates’ heads were scanned following these parameters: 
isotropic voxel size of 8.19 m, 30 kV, and 200 A. For brains, we 
rescanned heads, but they were previously soaked for 24 hours in 
Lugol’s iodine as a contrast agent following the work by Metscher 
(46). Scanning parameters for brain images with contrast were an 
isotropic voxel size of 8.19 m, 50 kV, and 160 A.
We used Amira software to build three-dimensional reconstructions 
and to register the position of anatomical points (landmarks). For 
skulls, a set of 42 bilateral landmarks was registered for each speci-
men, as described by Gonzalez et al. (fig. S13) (22). For brains, we 
followed the protocol proposed by Gonzalez et al. (22) to obtain the 
position of 57 landmarks and semilandmarks. Data collection was 
performed by one of the authors (J.B.-A.), who had previously applied 
the same protocol and measured the intraobserver error for this kind 
of data (22). Landmark and semilandmark coordinates were super-
imposed (Procrustes Analysis), and comprehensive measures of skull 
and brain size (centroid size) were obtained. Briefly, centroid size is 
defined as the square root of the summed squared distances of all 
digitized landmarks to the centroid of the configuration. Total brain 
size was estimated following this formula and using all the digitized 
points. In addition, since each point was digitized in an identifiable 
brain structure, for further analysis, we examined those landmarks 
and semilandmarks describing only the cortex. Figure S12 shows a 
transversal view of the cortex described by points 7 to 16, while in 
the sagittal, the cortex is represented by 16 to 23. Then, this restricted 
set of landmarks and semilandmarks describing the cortex was used 
to calculate cortex centroid size. A ratio between cortex and total brain 
centroid size was obtained for each experimental group as a variable 
to compare the proportion of the cortex in relation to the whole brain. 
Larger ratios correspond to brains in which cortex is relatively larger, 
while smaller ratios indicate that the cortex is relatively reduced.
While we did not digitize semilandmarks in the skull, in the 
brain, its structure demanded the use of semilandmarks (fig. S12). 
In this case, semilandmaks were sliced previously to superimposition 
using the function procSym of the Morpho R package.
The relationship between body weight and brain size was examined 
to understand whether the registered brain sizes correspond to the 
expected values for their body weights. For this purpose, a linear 
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model was carried out for the brain centroid size on body weight and 
the resulting residuals, which represent the deviations of the actual 
brain size of each case from the predicted value according to the 
body weight, as described by Gonzalez et al. (22). Positive values for 
the residuals indicate that brain size is larger than expected for certain 
body weight, while negative values suggest that brain size is smaller 
for body weight.
Statistical analyses
For all variables, a preliminary Kolmogorov-Smirnov test was carried 
out to test normality. Statistical analyses regarding comparisons be-
tween experimental groups were performed using analysis of variance 
(ANOVA), followed by a two-tailed least significant difference post 
hoc test with R, and a false discovery rate correction for multiple 
comparisons (47). Because of the distribution observed in the weight 
of E15 embryos, we performed a Bartlett test of homogeneity of 
variances using R as well. Before statistical analyses, we tested for 
power analysis according to our sample sizes by means of the func-
tion pwr.anova.test in R. For those variables that had at least one 
experimental group that departs from normality, we performed com-
parisons between means using the Kruskal-Wallis test, and in those 
cases in which significant difference was detected, we performed 
pairwise comparisons using Mann-Whitney U analyses. *P < 0.05, 
**P < 0.01, and ***P < 0.001.
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